港股早評:三大指數高開 科技股強勢 業績超預期小米大升5.59%
9月降息定了?隔夜美股三大指數集體收升,中概指數升2.39%。連續2日下跌的港股今日高開,恒指升0.61%,國指升0.82%,恒生科技指數升1.63%。盤面上,大型科技股全線上升,Q2業績超預期,小米大升5.59%,京東、百度升近3%,網易、阿里巴巴、美團升超1%,騰訊、快手皆上升;8月前三週新能源車市場零售49萬輛,同比增長58%,汽車股齊升,“蔚小理”均升超2%;免税概念股、餐飲股、內房股與物管股多數上升。另一方面,生物醫藥股部分下跌,石藥集團跌4%,藥明生物、石四藥集團跌超3.5%,內險股、石油股少數走低,友邦保險跌近2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.